Pradaxa and Haematocrit - a phase IV clinical study of FDA data

Summary:

Haematocrit is reported as a side effect among people who take Pradaxa (dabigatran etexilate mesylate), especially for people who are male, 60+ old, have been taking the drug for 1 - 6 months also take Ramipril, and have Pain.

The phase IV clinical study analyzes which people have Haematocrit when taking Pradaxa. It is created by eHealthMe based on reports of 86,033 people who have side effects when taking Pradaxa from the FDA, and is updated regularly.

What is Pradaxa?

Pradaxa has active ingredients of dabigatran etexilate mesylate. It is often used in atrial fibrillation/flutter. eHealthMe is studying from 86,906 Pradaxa users. Check the latest studies of Pradaxa.

What is Haematocrit?

Haematocrit is found to be associated with 269 drugs and 576 conditions by eHealthMe. Check the latest studies of Haematocrit.

On Aug, 12, 2026

86,033 people reported to have side effects when taking Pradaxa.
Among them, 18 people (0.02%) have Haematocrit.

Among these 18 people:

How long have people been on Pradaxa when they have Haematocrit? *

What is the gender of people who have Haematocrit when taking Pradaxa? *

female: 44.44 %
male: 55.56 %

What is the age of people who have Haematocrit when taking Pradaxa? *

What are other drugs people take besides Pradaxa? *

What are other side effects people have besides Haematocrit? *

Haemoglobin Abnormal: 13 people, 72.22%
Aortic Arteriosclerosis (hardening of the aortic arteries): 10 people, 55.56%
Hiatal Hernia (hernia resulting from the protrusion of part of the stomach through the diaphragm): 10 people, 55.56%
Haemoglobin Decreased: 9 people, 50.00%
Hepatic Cyst: 8 people, 44.44%
Mean Cell Volume Increased (more than normal average red blood cell volume): 8 people, 44.44%
Mean Cell Haemoglobin Increased (more than normal haemoglobin per red blood cell in a sample of blood): 8 people, 44.44%
Lymph Follicular Hypertrophy (an increase in the size of the lymph node follicles): 8 people, 44.44%
Lordosis (outward curve of the back bone): 8 people, 44.44%
International Normalised Ratio Abnormal: 8 people, 44.44%

What are the existing conditions these people have? *

Pain: 10 people, 55.56%
Renal Cell Carcinoma (a kidney cancer): 8 people, 44.44%
Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development): 3 people, 16.67%
Oedema (fluid collection in tissue): 2 people, 11.11%
Myelodysplastic Syndrome (a group of conditions that occur when the blood-forming cells in the bone marrow are damaged): 2 people, 11.11%
Haemoglobin Abnormal: 2 people, 11.11%
Anaemia (lack of blood): 2 people, 11.11%
Sleep Disorder: 1 person, 5.56%
Indigestion: 1 person, 5.56%
Crohn's Disease (a condition that causes inflammation of the gastrointestinal tract): 1 person, 5.56%

* Approximation only. Some reports may have incomplete information.

Do you take Pradaxa and have Haematocrit?

- Check whether Haematocrit is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Pradaxa:

Pradaxa (86,906 reports)

Haematocrit treatments and more:

Haematocrit (407 reports)

Browse all side effects of Pradaxa:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Haematocrit:

Haematocrit (269 drugs)

Browse all the conditions that are associated with Haematocrit:

Haematocrit (576 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on dabigatran etexilate mesylate (the active ingredients of Pradaxa) and Pradaxa (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.